SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-21-000060
Filing Date
2021-04-23
Accepted
2021-04-23 16:11:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A shareholdermeetingnotice.htm DEFA14A 13146
2 image_01a.jpg GRAPHIC 384238
3 image_02.jpg GRAPHIC 12141
4 image_11a.jpg GRAPHIC 313282
  Complete submission text file 0000886163-21-000060.txt   986014
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 21849825
SIC: 2834 Pharmaceutical Preparations